Therapeutic approach to patients with acute ischaemic stroke and intracranial atherosclerotic stenoses
Keywords:
ischaemic stroke, intracranial atherosclerotic stenosesAbstract
Intracranial atherosclerotic stenoses (ICAS) are one of the most common causes of ischaemic strokes worldwide. Current therapeutic approach concerning patients with acute ischaemic stroke and ICAS includes conservative medical treatment and control of vascular risk factors. Although endovascular therapy has also been proposed over the years, it hasn’t been shown to be beneficial over conservative treatment. The aim of the current study is to present the early outcome among 98 patients with acute ischaemic stroke and intracranial stenosis, according to different therapeutic approach (intravenous thrombolysis, endovascular treatment or bridging-therapy).
References
Milanov, I., Stamenova, P. (2020). National consensus statement for prophylaxis, making the diagnosis and treatment of cerebrovascular diseases. Bulgarian Neurology, 21(S4), 1–31. Retrieved from https://www.nevrologiabg.com/journal/index.php/neurology/article/view/29
Abou-Chebl, A., Steinmetz, H. Critique of “Stenting Versus Aggressive Medical Therapy for Intracranial Arterial Stenosis” by Chimowitz et al in the New England Journal of Medicine. Stroke, 2012, 43, 616-620.
Alexander, M.J., Zauner, A., Chaloupka, J.C., Baxter, B., Callison, R.C., Gupta, R., Song, S.S., Yu, W, WEAVE Trial Sites and Interventionalists. WEAVE Trial: Final Results in 152 On-Label Patients. Stroke. 2019, 50, 4, 889-894.
Baek, J.H., Kim, B.M., Heo, J.H., Kim, D.J., Nam, H.S., Kim, Y.D. Outcomes of Endovascular Treatment for Acute Intracranial Atherosclerosis-Related Large Vessel Occlusion. Stroke, 2018, 49, 11, 2699-2705.
Bose, A., Hartmann, M., Henkes, H., Liu, H.M., Teng, M.M., Szikora, I., et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke, 2007, 38, 1531-1537.
Chimowitz, M.I., Lynn, M.J., Derdeyn, C.P., Turan, T.N., Fiorella, D., Lane, B.F., et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med, 2011, 365, 993-1003.
Derdeyn, C.P., Chimowitz, M.I., Lynn, M.J., et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet, 2014, 383, 331-341.
Fiorella, D. Endovascular Treatment of Intracranial Stenosis. World Neurosurgery, 2011, 76, 6, 66-70.
Fiorella, D., Derdeyn, C.P., Lynn, M.J., Barnwell, S.L., Hoh, B.L., Levy, E.I., et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS). Stroke, 2012, 43, 2682-2688.
Holmstedt, C.A., Turan, T.N., Chimowitz, M.I. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol, 2013, 12, 11, 1106-1114.
Jafari, M., Nguyen, T.N., Ortega-Gutierrez, S., Hussain, M.S., Hassan, A.E., Ikram, A., Eliyas, J.K., Rodriguez, G.J., Divani, A.A. Current Advances in Endovascular Treatment of Intracranial Atherosclerotic Disease and Future Prospective. J Stroke Cerebrovasc Dis, 2021, 30, 3, 105556.
Jung, S., Mattle, H., Horvath, T., Seiffge, D., Heldner, M., Arnold, M., Stroke Guidelines of the Bern Stroke Network, 2021, 7, 18-19.
Kang, D., Yoon, W., Kim, S. K., Baek, B. H., Lee, Y. Y., Kim, Y., Kim, Y., Hwang, Y., Kim, J., & Park, M. S. Endovascular treatment for emergent large vessel occlusion due to severe intracranial atherosclerotic stenosis. Journal of Neurosurgery JNS, 2019, 130, 6, 1949-1956.
Kernan, W.N., et al. 2014 AHA/ASA Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2014, 45, 2160-2236.
Kim, D.J. Intracranial Stenting; the Current Landscape. Neurointervention. 2021, 16, 1, 2-5.
Lutsep, H.L., Lynn, M.J., Cotsonis, G.A., Derdeyn, C.P., Turan, T.N., Fiorella, D., et al. Does SAMMPRIS Support Stenting Over Medical Therapy for Subpopulations of Patients with Intracranial Arterial Stenosis? Stroke, 2015, 46, 11, 3282-3284.
Qureshi, A.I., Caplan, L.R. Intracranial atherosclerosis. Lancet, 2014, 383, 984-999.
Wong, K.S., et al. Prevalence of symptomatic intracranial atherosclerosis in high-risk patients. Neurology, 2007, 68, 2035–2038.
Zaidat, O.O., Fitzsimmons, B.F., Woodward, B.K., et al., Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA, 2015, 313, 1240-1248.
Downloads
Published
How to Cite
Issue
Section
ARK
License
Copyright (c) 2021 Marina Krasteva, E. Vassileva
This work is licensed under a Creative Commons Attribution 4.0 International License.
